 The Miami Project faculty is a multidisciplinary team comprised of both basic and clinical scientists with expertise in neuroscience.
Read a Message from the Scientific Director, W. Dalton Dietrich, Ph.D.
|
The Project, published bi-annually is the official magazine of The Miami Project and The Buoniconti Fund and is available electronically. Our Annual Research Review summarizes a selection of research publications from the past year.
|
|
 Our broad scope of collaborative research is dedicated to finding new treatments for spinal cord injury.
Read a Message from the Chairman, Barth A. Green, M.D.
|
Schwann Cell Trial to include Participants with Subacute Spinal Cord Injury
The Miami Project to Cure Paralysis, at the University of Miami Miller School of Medicine has submitted today its first Investigational New Drug (IND) application to the Food and Drug Administration (FDA) requesting permission to begin a Phase I clinical trial to evaluate the safety of autologous human Schwann cell transplantation in the subacute spinal cord injury (SCI) setting.
The clinical protocol of the Phase I trial is strictly focused on safety outcomes. Therefore, the proposed clinical trial is designed to enroll 8 participants with complete thoracic SCI. Newly injured patients would have to meet the stringent inclusion/exclusion criteria and agree to participate in further screening within 5 days after their injury, which is considered the acute phase. At that point, the participant will have a biopsy of a sensory nerve in one leg to obtain his or her own Schwann cells. The Schwann cells will then need to grow in a culturing facility for 3 to 5 weeks to generate the number of cells necessary for transplantation, and to undergo the strict purification process. By the time the Schwann cells are transplanted into the site of spinal cord injury, the participant will be 26-40 days post-injury, which is considered the sub-acute phase.
Led by W. Dalton Dietrich, Ph.D., Scientific Director, The Miami Project to Cure Paralysis, the Schwann cell clinical trial team is comprised of a multi-disciplinary group of faculty level scientists, neurosurgeons, and staff focused on advancing the trial.
Read more
|
|
|
 Years in the making, with unprecedented scientific triumphs, we are actively moving ahead with a Clinical Trials Initiative. Indeed this is an exciting endeavor.
Watch our Video.
|
|
Monday, September 24, 2012
Twenty Seventh Annual Great Sports Legends Dinner
Waldorf=Astoria
New York, New York
Learn more
Friday, May 11, 2012
(1:00pm-2:00pm)
Neuroscience Center Seminar Series
Lois Pope LIFE Center Building
Apex Auditorium -7th Floor
Stephe Baccus,PhD
Assistant Professor
Department of Neurobiology
Stanford Institute for Neuro-Innovation & Translational Neuroscience
"Adaptive Computations in the Retina"
Saturday, November 10, 2012
Destination Fashion
Bal Harbour Shops
Bal Harbour, Florida
Learn more
|
|
|